{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:24:42Z","timestamp":1789597482626,"version":"build-2803163510"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.7759\/cureus.95613","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:44:09Z","timestamp":1761680649000},"source":"Crossref","is-referenced-by-count":1,"title":["Strategies and Recent Advances in Tackling Antibacterial Resistance in India: A Comprehensive Narrative Review"],"prefix":"10.7759","author":[{"given":"Tanmay","family":"Goudar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunatha","family":"Basappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50457-z","article-title":"Antimicrobial resistance: a silent pandemic","volume":"15","year":"2024","unstructured":"Antimicrobial resistance. a silent pandemic. Nat Commun. 2024, 15:6198. 10.1038\/s41467-024-50457-z","journal-title":"Nat Commun"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2021.10.020","article-title":"Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects","volume":"14","author":"Uddin TM","year":"2021","unstructured":"Uddin TM, Chakraborty AJ, Khusro A, et al.. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J Infect Public Health. 2021, 14:1750-1766.","journal-title":"J Infect Public Health"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2020.10.009","article-title":"Antibiotic resistance surveillance systems: a review","volume":"23","author":"Diallo OO","year":"2020","unstructured":"Diallo OO, Baron SA, Abat C, et al.. Antibiotic resistance surveillance systems: a review. J Glob Antimicrob Resist. 2020, 23:430-438.","journal-title":"J Glob Antimicrob Resist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-021-04008-9","article-title":"Antimicrobial resistance: the 'other' pandemic!","volume":"89","author":"Singhal T","year":"2022","unstructured":"Singhal T. Antimicrobial resistance: the 'other' pandemic!. Indian J Pediatr. 2022, 89:600-6. 10.1007\/s12098-021-04008-9","journal-title":"Indian J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: Impacts, challenges, and future prospects","volume":"2","author":"Ahmed SK","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, et al.. Antimicrobial resistance: Impacts, challenges, and future prospects. J Med Surg Public Health. 2024, 2:Article number 100081. 10.1016\/j.glmedi.2024.100081","journal-title":"J Med Surg Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-023-03800-9","article-title":"An insights into emerging trends to control the threats of antimicrobial resistance (AMR): An address to public health risks","volume":"206","author":"Asghar A","year":"2024","unstructured":"Asghar A, Khalid A, Baqar Z, et al.. An insights into emerging trends to control the threats of antimicrobial resistance (AMR): An address to public health risks. Arch Microbiol. 2024, 206:Article number 72. 10.1007\/s00203-023-03800-9","journal-title":"Arch Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0208-x","article-title":"The threat of antimicrobial resistance in developing countries: causes and control strategies","volume":"6","author":"Ayukekbong JA","year":"2017","unstructured":"Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017, 6:47. 10.1186\/s13756-017-0208-x","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_19_17","article-title":"Combating antimicrobial resistance in India: Technical challenges and opportunities","volume":"146","author":"Bhatia R","year":"2017","unstructured":"Bhatia R, Walia K. Combating antimicrobial resistance in India: Technical challenges and opportunities. Indian J Med Res. 2017, 146:683-7. 10.4103\/ijmr.IJMR_19_17","journal-title":"Indian J Med Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1347750","article-title":"Combating antimicrobial resistance: the silent war","volume":"15","author":"Bo L","year":"2024","unstructured":"Bo L, Sun H, Li YD, et al.. Combating antimicrobial resistance: the silent war. Front Pharmacol. 2024, 15:1347750. 10.3389\/fphar.2024.1347750","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5419874","article-title":"Multidrug-resistant bacteria: their mechanism of action and prophylaxis","volume":"2022","author":"Bharadwaj A","year":"2022","unstructured":"Bharadwaj A, Rastogi A, Pandey S, et al.. Multidrug-resistant bacteria: their mechanism of action and prophylaxis. Biomed Res Int. 2022, 2022:5419874. 10.1155\/2022\/5419874","journal-title":"Biomed Res Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.22207\/JPAM.18.1.53","article-title":"Antimicrobial resistance: techniques to fight AMR in bacteria - a review","volume":"18","author":"Mahizhchi E","year":"2024","unstructured":"Mahizhchi E, Sivakumar D, Megala J. Antimicrobial resistance: techniques to fight AMR in bacteria - a review. J Pure Appl Microbiol. 2024, 18:16-28. 10.22207\/JPAM.18.1.53","journal-title":"J Pure Appl Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"Mohsen N","year":"2024","unstructured":"Mohsen N. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024, 404:1199-226. 10.1016\/S0140-6736(24)01867-1","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.100359","article-title":"Epidemiology of rare bacterial, parasitic, and fungal pathogens in India","volume":"11","author":"Sharma S","year":"2024","unstructured":"Sharma S, Krishnaswamy V, Chaturvedi R, Sharma A. Epidemiology of rare bacterial, parasitic, and fungal pathogens in India. IJID Reg. 2024, 11:100359. 10.1016\/j.ijregi.2024.100359","journal-title":"IJID Reg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_2104_23","article-title":"Environmental aspects of antimicrobial resistance in India: Current progress and way forward","volume":"159","author":"Bhatia R","year":"2024","unstructured":"Bhatia R. Environmental aspects of antimicrobial resistance in India: Current progress and way forward. Indian J Med Res. 2024, 159:10-5. 10.4103\/ijmr.ijmr_2104_23","journal-title":"Indian J Med Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1049732320919088","article-title":"Antimicrobial resistance, politics, and practice in India","volume":"30","author":"Broom A","year":"2020","unstructured":"Broom A, Doron A. Antimicrobial resistance, politics, and practice in India. Qual Health Res. 2020, 30:1684-1696. 10.1177\/1049732320919088","journal-title":"Qual Health Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114520","article-title":"Resistant bugs, porous borders and ecologies of care in India","volume":"292","author":"Broom A","year":"2022","unstructured":"Broom A, Doron A. Resistant bugs, porous borders and ecologies of care in India. Soc Sci Med. 2022, 292:Article number 114520. 10.1016\/j.socscimed.2021.114520","journal-title":"Soc Sci Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1077_19","article-title":"Antimicrobial resistance: call for rational antibiotics practice in India","volume":"9","author":"Chandra S","year":"2020","unstructured":"Chandra S, Prithvi PP, Srija K, et al.. Antimicrobial resistance: call for rational antibiotics practice in India. J Family Med Prim Care. 2020, 9:2192-9. 10.4103\/jfmpc.jfmpc_1077_19","journal-title":"J Family Med Prim Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3535","article-title":"Fostering research into antimicrobial resistance in India","volume":"358","author":"Das B","year":"2017","unstructured":"Das B, Chaudhuri S, Srivastava R, et al.. Fostering research into antimicrobial resistance in India. BMJ. 2017, 358:j3535. 10.1136\/bmj.j3535","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy955","article-title":"The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study","volume":"69","author":"Gandra S","year":"2019","unstructured":"Gandra S, Tseng KK, Arora A, et al.. The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study. Clin Infect Dis. 2019, 69:563-70. 10.1093\/cid\/ciy955","journal-title":"Clin Infect Dis"},{"key":"ref20","article-title":"Rationalizing antibiotic use to limit antibiotic resistance in India","volume":"134","author":"Ganguly NK","year":"2011","unstructured":"Ganguly NK, Arora NK, Chandy SJ, et al.. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011, 134:281-294.","journal-title":"Indian J Med Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1756285","article-title":"A silent pandemic of antimicrobial resistance: Challenges and strategy for preparedness in India","volume":"58","author":"Gupta YK","year":"2022","unstructured":"Gupta YK, Srinivasan S. A silent pandemic of antimicrobial resistance: Challenges and strategy for preparedness in India. Ann Natl Acad Med Sci (India). 2022, 58:55-59. 10.1055\/s-0042-1756285","journal-title":"Ann Natl Acad Med Sci (India)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2024.100412","article-title":"Emerging trends in antimicrobial resistance in bloodstream infections: multicentric longitudinal study in India (2017-2022)","volume":"26","author":"Kaur J","year":"2024","unstructured":"Kaur J, Singh H, Sethi T. Emerging trends in antimicrobial resistance in bloodstream infections: multicentric longitudinal study in India (2017-2022). Lancet Reg Health Southeast Asia. 2024, 26:100412. 10.1016\/j.lansea.2024.100412","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0976-9668.116970","article-title":"Antimicrobial resistance in India: a review","volume":"4","author":"Kumar SG","year":"2013","unstructured":"Kumar SG, Adithan C, Harish BN, et al.. Antimicrobial resistance in India: a review. J Nat Sci Biol Med. 2013, 4:286-91. 10.4103\/0976-9668.116970","journal-title":"J Nat Sci Biol Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001974","article-title":"Antibiotic resistance in India: Drivers and opportunities for action","volume":"13","author":"Laxminarayan R","year":"2016","unstructured":"Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: Drivers and opportunities for action. PLoS Med. 2016, 13:e1001974. 10.1371\/journal.pmed.1001974","journal-title":"PLoS Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84293-8","article-title":"A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India","volume":"11","author":"Mogasale VV","year":"2021","unstructured":"Mogasale VV, Saldanha P, Pai V, et al.. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Sci Rep. 2021, 11:5116. 10.1038\/s41598-021-84293-8","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00760-3","article-title":"A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance","volume":"9","author":"Mutua F","year":"2020","unstructured":"Mutua F, Sharma G, Grace D, et al.. A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance. Antimicrob Resist Infect Control. 2020, 9:103. 10.1186\/s13756-020-00760-3","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-017-0118-6","article-title":"Antimicrobial resistance in India","volume":"10","author":"Patel I","year":"2017","unstructured":"Patel I, Hussain R, Khan A, et al.. Antimicrobial resistance in India. J Pharm Policy Pract. 2017, 10:27. 10.1186\/s40545-017-0118-6","journal-title":"J Pharm Policy Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1296382","article-title":"Social and biological evaluation of antimicrobial resistance (SOBEAR) in rural India: a study protocol","volume":"12","author":"Pattnaik M","year":"2024","unstructured":"Pattnaik M, Nayak AK, Karna S, et al.. Social and biological evaluation of antimicrobial resistance (SOBEAR) in rural India: a study protocol. Front Public Health. 2024, 12:1296382. 10.3389\/fpubh.2024.1296382","journal-title":"Front Public Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42231","article-title":"The challenge of antimicrobial resistance in the Indian healthcare system","volume":"15","author":"Sharma A","year":"2023","unstructured":"Sharma A, Thakur N, Thakur A, et al.. The challenge of antimicrobial resistance in the Indian healthcare system. Cureus. 2023, 15:e42231. 10.7759\/cureus.42231","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jafr.2024.100973","article-title":"A mini-review on the burden of antimicrobial resistance and its regulation across one health sectors in India","volume":"15","author":"Singh VP","year":"2024","unstructured":"Singh VP, Jha D, Rehman BU, et al.. A mini-review on the burden of antimicrobial resistance and its regulation across one health sectors in India. J Agric Food Res. 2024, 15:Article number 100973. 10.1016\/j.jafr.2024.100973","journal-title":"J Agric Food Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_2444_21","article-title":"Integrated antimicrobial resistance management strategy: A way forward to mitigate antimicrobial resistance crisis","volume":"156","author":"Tamhankar AJ","year":"2022","unstructured":"Tamhankar AJ, Diwan V. Integrated antimicrobial resistance management strategy: A way forward to mitigate antimicrobial resistance crisis. Indian J Med Res. 2022, 156:615-8. 10.4103\/ijmr.ijmr_2444_21","journal-title":"Indian J Med Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_331_18","article-title":"Antimicrobial resistance in the environment: The Indian scenario","volume":"149","author":"Taneja N","year":"2019","unstructured":"Taneja N, Sharma M. Antimicrobial resistance in the environment: The Indian scenario. Indian J Med Res. 2019, 149:119-28. 10.4103\/ijmr.IJMR_331_18","journal-title":"Indian J Med Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44666","article-title":"An overview of preventive strategies and the role of various organizations in combating antimicrobial resistance","volume":"15","author":"Shelke YP","year":"2023","unstructured":"Shelke YP, Bankar NJ, Bandre GR, et al.. An overview of preventive strategies and the role of various organizations in combating antimicrobial resistance. Cureus. 2023, 15:e44666. 10.7759\/cureus.44666","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1403168","article-title":"Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability","volume":"15","author":"Sharma S","year":"2024","unstructured":"Sharma S, Chauhan A, Ranjan A, et al.. Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability. Front Microbiol. 2024, 15:1403168. 10.3389\/fmicb.2024.1403168","journal-title":"Front Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw475","article-title":"World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies to control antimicrobial resistance from food animal production","volume":"63","author":"Collignon PC","year":"2016","unstructured":"Collignon PC, Conly JM, Andremont A, et al.. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies to control antimicrobial resistance from food animal production. CID. 2016, 63:1087-1093. 10.1093\/cid\/ciw475","journal-title":"CID"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2023.100011","article-title":"One Health approaches adapted in low resource settings to address antimicrobial resistance","volume":"1","author":"Biswas R","year":"2022","unstructured":"Biswas R, Debnath C, Bandyopadhyay S, Samanta I. One Health approaches adapted in low resource settings to address antimicrobial resistance. Sci One Health. 2022, 1:100011. 10.1016\/j.soh.2023.100011","journal-title":"Sci One Health"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020200","article-title":"Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics","volume":"11","author":"Murugaiyan J","year":"2022","unstructured":"Murugaiyan J, Kumar PA, Rao GS, et al.. Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics. Antibiotics (Basel). 2022, 11:10.3390\/antibiotics11020200","journal-title":"Antibiotics (Basel)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.12.008","article-title":"Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility","volume":"15","author":"Sharma A","year":"2022","unstructured":"Sharma A, Singh A, Dar MA, et al.. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. J Infect Public Health. 2022, 15:172-181. 10.1016\/j.jiph.2021.12.008","journal-title":"J Infect Public Health"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-024-01046-8","article-title":"AMR and sustainable development goals: at a crossroads","volume":"20","author":"Aslam B","year":"2024","unstructured":"Aslam B, Asghar R, Muzammil S, et al.. AMR and sustainable development goals: at a crossroads. Global Health. 2024, 20:73. 10.1186\/s12992-024-01046-8","journal-title":"Global Health"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-022-03029-7","article-title":"Emerging non-traditional approaches to combat antibiotic resistance","volume":"79","author":"Konwar AN","year":"2022","unstructured":"Konwar AN, Hazarika SN, Bharadwaj P, Thakur D. Emerging non-traditional approaches to combat antibiotic resistance. Curr Microbiol. 2022, 79:330. 10.1007\/s00284-022-03029-7","journal-title":"Curr Microbiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.22207\/JPAM.18.1.42","article-title":"Novel insights into the antimicrobial resistance and strategies to curb the menace","volume":"18","author":"Panda B","year":"2024","unstructured":"Panda B, Rath PK, Mishra BP, et al.. Novel insights into the antimicrobial resistance and strategies to curb the menace. J Pure Appl Microbiol. 2024, 18:1-15. 10.22207\/JPAM.18.1.42","journal-title":"J Pure Appl Microbiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2024.100379","article-title":"Community engagement to mitigate antimicrobial resistance in low-and middle-income countries - an essential strategy for implementation of national action plans on AMR","volume":"24","author":"Mathew P","year":"2024","unstructured":"Mathew P, Chandy SJ, Ranjalkar J. Community engagement to mitigate antimicrobial resistance in low-and middle-income countries - an essential strategy for implementation of national action plans on AMR. Lancet Reg Health Southeast Asia. 2024, 24:100379. 10.1016\/j.lansea.2024.100379","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201400593","article-title":"","author":"Koller PK","year":"2013","unstructured":"Koller PK. Antibiotics: Targets, Mechanisms and Resistance. Gualerzi CO, Brandi L, Fabbretti A, Pon CL (ed): Wiley\u2010VCH, Weinheim; 2013. 10.1002\/anie.201400593"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.46.070177.003451","article-title":"Polymyxin and related peptide antibiotics","volume":"46","author":"Storm DR","year":"1977","unstructured":"Storm DR, Rosenthal KS, Swanson PE. Polymyxin and related peptide antibiotics. Annu Rev Biochem. 1977, 46:723-63. 10.1146\/annurev.bi.46.070177.003451","journal-title":"Annu Rev Biochem"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson T","year":"2003","unstructured":"Tenson T, Lovmar M, Ehrenberg M. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol. 2003, 330:1005-1014. 10.1016\/s0022-2836(03)00662-4","journal-title":"J Mol Biol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica K","year":"1997","unstructured":"Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997, 61:377-92. 10.1128\/mmbr.61.3.377-392.1997","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112268","article-title":"Dihydrofolate reductase inhibitors for use as antimicrobial agents","volume":"195","author":"He J","year":"2020","unstructured":"He J, Qiao W, An Q, et al.. Dihydrofolate reductase inhibitors for use as antimicrobial agents. Eur J Med Chem. 2020, 195:112268. 10.1016\/j.ejmech.2020.112268","journal-title":"Eur J Med Chem"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1086\/319370","article-title":"Mechanisms of action of antimicrobials: focus on fluoroquinolones","volume":"32 Suppl 1","author":"Hooper DC","year":"2001","unstructured":"Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis. 2001, 32 Suppl 1:S9-S15. 10.1086\/319370","journal-title":"Clin Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson DN","year":"2014","unstructured":"Wilson DN. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 2014, 12:35-48. 10.1038\/nrmicro3155","journal-title":"Nat Rev Microbiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman D","year":"2008","unstructured":"Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev. 2008, 21:449-65. 10.1128\/CMR.00006-08","journal-title":"Clin Microbiol Rev"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1134\/S0003683823603104","article-title":"Mechanisms of action, biological characteristics, and future prospects: A review of antimicrobial peptides (a review)","volume":"60","author":"Ma X","year":"2024","unstructured":"Ma X, Chen Z, Long M. Mechanisms of action, biological characteristics, and future prospects: A review of antimicrobial peptides (a review). Appl Biochem Microbiol. 2024, 60:1044-1060. 10.1134\/S0003683823603104","journal-title":"Appl Biochem Microbiol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-024-04106-8","article-title":"Mechanism-guided strategies for combating antibiotic resistance","volume":"40","author":"Sun S","year":"2024","unstructured":"Sun S, Chen X. Mechanism-guided strategies for combating antibiotic resistance. World J Microbiol Biotechnol. 2024, 40:295. 10.1007\/s11274-024-04106-8","journal-title":"World J Microbiol Biotechnol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-021-00343-2","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang QY","year":"2021","unstructured":"Zhang QY, Yan ZB, Meng YM, et al.. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021, 8:48. 10.1186\/s40779-021-00343-2","journal-title":"Mil Med Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.08.002","article-title":"Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014","volume":"50","author":"Gandra S","year":"2016","unstructured":"Gandra S, Mojica N, Klein EY, et al.. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. Int J Infect Dis. 2016, 50:75-82. 10.1016\/j.ijid.2016.08.002","journal-title":"Int J Infect Dis"},{"key":"ref55","unstructured":"Indian Council of Medical Research. Welcome to antimicrobial resistance surveillance and research network (AMRSN) of ICMR. (2025). Accessed: October 27, 2025: https:\/\/iamrsn.icmr.org.in\/."},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_226_18","article-title":"Establishing antimicrobial resistance surveillance & research network in India: journey so far","volume":"149","author":"Walia K","year":"2019","unstructured":"Walia K, Madhumathi J, Veeraraghavan B, et al.. Establishing antimicrobial resistance surveillance & research network in India: journey so far. Indian J Med Res. 2019, 149:164-79. 10.4103\/ijmr.IJMR_226_18","journal-title":"Indian J Med Res"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.06.028","article-title":"Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a single-center retrospective study of 75 cases in India","volume":"45","author":"Kaur A","year":"2017","unstructured":"Kaur A, Gandra S, Gupta P, et al.. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a single-center retrospective study of 75 cases in India. Am J Infect Control. 2017, 45:1289-91. 10.1016\/j.ajic.2017.06.028","journal-title":"Am J Infect Control"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02135","article-title":"Molecular mechanisms of colistin resistance in klebsiella pneumoniae causing bacteremia from India-a first report","volume":"7","author":"Pragasam AK","year":"2016","unstructured":"Pragasam AK, Shankar C, Veeraraghavan B, et al..  Molecular mechanisms of colistin resistance in klebsiella pneumoniae causing bacteremia from India-a first report. Front Microbiol. 2016, 7:2135. 10.3389\/fmicb.2016.02135","journal-title":"Front Microbiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000508","article-title":"The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India","volume":"66","author":"Manohar P","year":"2017","unstructured":"Manohar P, Shanthini T, Ayyanar R, et al.. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India. J Med Microbiol. 2017, 66:874-83. 10.1099\/jmm.0.000508","journal-title":"J Med Microbiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(16)30148-6","article-title":"Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: A cohort study","volume":"4","author":"Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration","year":"2016","unstructured":"Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration. Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: A cohort study. Lancet Glob Health. 2016, 4:752-760. 10.1016\/s2214-109x(16)30148-6","journal-title":"Lancet Glob Health"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122267","article-title":"Amikacin: Uses, resistance, and prospects for inhibition","volume":"22","author":"Ramirez MS","year":"2017","unstructured":"Ramirez MS, Tolmasky ME. Amikacin: Uses, resistance, and prospects for inhibition. Molecules. 2017, 22:10.3390\/molecules22122267","journal-title":"Molecules"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira DM","year":"2020","unstructured":"De Oliveira DM, Forde BM, Kidd TJ, et al.. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020, 33:10.1128\/CMR.00181-19","journal-title":"Clin Microbiol Rev"},{"key":"ref63","article-title":"Antitubercular drug resistance in four healthcare facilities in North India","volume":"29","author":"Gupta A","year":"2011","unstructured":"Gupta A, Mathuria JP, Singh SK, et al.. Antitubercular drug resistance in four healthcare facilities in North India. J Health Popul Nutr. 2011, 29:583-92.","journal-title":"J Health Popul Nutr"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.965053","article-title":"Bacterial profile and antibiotic susceptibility pattern of uropathogens causing urinary tract infection in the eastern part of Northern India","volume":"13","author":"Bhargava K","year":"2022","unstructured":"Bhargava K, Nath G, Bhargava A, et al.. Bacterial profile and antibiotic susceptibility pattern of uropathogens causing urinary tract infection in the eastern part of Northern India. Front Microbiol. 2022, 13:965053. 10.3389\/fmicb.2022.965053","journal-title":"Front Microbiol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.540","article-title":"Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis","volume":"41","author":"Scorpio A","year":"1997","unstructured":"Scorpio A, Lindholm-Levy P, Heifets L, et al.. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1997, 41:540-3. 10.1128\/AAC.41.3.540","journal-title":"Antimicrob Agents Chemother"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2021022","article-title":"Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications","volume":"43","author":"Husain AA","year":"2021","unstructured":"Husain AA, Kupz A, Kashyap RS. Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications. Epidemiol Health. 2021, 43:e2021022. 10.4178\/epih.e2021022","journal-title":"Epidemiol Health"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90417-f","article-title":"Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis","volume":"341","author":"Telenti A","year":"1993","unstructured":"Telenti A, Imboden P, Marchesi F, et al.. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993, 341:647-650. 10.1016\/0140-6736(93)90417-f","journal-title":"Lancet"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1677","article-title":"Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations","volume":"41","author":"Sreevatsan S","year":"1997","unstructured":"Sreevatsan S, Stockbauer KE, Pan X, et al.. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother. 1997, 41:1677-81. 10.1128\/AAC.41.8.1677","journal-title":"Antimicrob Agents Chemother"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3201\/eid1309.070443","article-title":"Extensively drug-resistant Mycobacterium tuberculosis, India","volume":"13","author":"Mondal R","year":"2007","unstructured":"Mondal R, Jain A. Extensively drug-resistant Mycobacterium tuberculosis, India. Emerg Infect Dis. 2007, 13:1429-31. 10.3201\/eid1309.070443","journal-title":"Emerg Infect Dis"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_177_16","article-title":"Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management","volume":"145","author":"Prasad R","year":"2017","unstructured":"Prasad R, Singh A, Balasubramanian V, Gupta N. Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management. Indian J Med Res. 2017, 145:271-93. 10.4103\/ijmr.IJMR_177_16","journal-title":"Indian J Med Res"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.938032","article-title":"Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement","volume":"12","author":"Singh A","year":"2022","unstructured":"Singh A, Zhao X, Drlica K. Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement. Front Cell Infect Microbiol. 2022, 12:938032. 10.3389\/fcimb.2022.938032","journal-title":"Front Cell Infect Microbiol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3387-3392.2001","article-title":"Intrinsic resistance of Mycobacteriumsmegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA","volume":"45","author":"Montero C","year":"2001","unstructured":"Montero C, Mateu G, Rodriguez R, Takiff H. Intrinsic resistance of Mycobacteriumsmegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob Agents Chemother. 2001, 45:3387-92. 10.1128\/AAC.45.12.3387-3392.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3192-3197.2005","article-title":"Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis","volume":"49","author":"Maus CE","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005, 49:3192-7. 10.1128\/AAC.49.8.3192-3197.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50222","article-title":"Multi-drug resistance tuberculosis (MDR-TB) challenges in India: a review","volume":"15","author":"Vishwakarma D","year":"2023","unstructured":"Vishwakarma D, Gaidhane A, Sahu S, Rathod AS. Multi-drug resistance tuberculosis (MDR-TB) challenges in India: a review. Cureus. 2023, 15:e50222. 10.7759\/cureus.50222","journal-title":"Cureus"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(16)30040-8","article-title":"Multidrug-resistant tuberculosis in India: looking back, thinking ahead","volume":"2","author":"Fojo AT","year":"2017","unstructured":"Fojo AT, Dowdy DW. Multidrug-resistant tuberculosis in India: looking back, thinking ahead. Lancet Public Health. 2017, 2:8-9. 10.1016\/S2468-2667(16)30040-8","journal-title":"Lancet Public Health"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio A","year":"1996","unstructured":"Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med. 1996, 2:662-7. 10.1038\/nm0696-662","journal-title":"Nat Med"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2020.1853733","article-title":"Mycobacterial ethambutol responsive genes and implications in antibiotics resistance","volume":"29","author":"Xiang X","year":"2021","unstructured":"Xiang X, Gong Z, Deng W, et al.. Mycobacterial ethambutol responsive genes and implications in antibiotics resistance. J Drug Target. 2021, 29:284-93. 10.1080\/1061186X.2020.1853733","journal-title":"J Drug Target"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.159561","article-title":"Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases","volume":"32","author":"Kalo D","year":"2015","unstructured":"Kalo D, Kant S, Srivastava K, Sharma AK. Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases. Lung India. 2015, 32:339-41. 10.4103\/0970-2113.159561","journal-title":"Lung India"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4779-5","article-title":"Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis","volume":"17","author":"Goyal V","year":"2017","unstructured":"Goyal V, Kadam V, Narang P, Singh V. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis. BMC Public Health. 2017, 17:817. 10.1186\/s12889-017-4779-5","journal-title":"BMC Public Health"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.11.007","article-title":"Variations in rifampicin and isoniazid resistance associated genetic mutations among drug na\u00efve and recurrence cases of pulmonary tuberculosis","volume":"103","author":"Kabir S","year":"2021","unstructured":"Kabir S, Junaid K, Rehman A. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug na\u00efve and recurrence cases of pulmonary tuberculosis. Int J Infect Dis. 2021, 103:56-61. 10.1016\/j.ijid.2020.11.007","journal-title":"Int J Infect Dis"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/s44259-024-00025-8","article-title":"Going to extremes: progress in exploring new environments for novel antibiotics","volume":"2","author":"Quinn GA","year":"2024","unstructured":"Quinn GA, Dyson PJ. Going to extremes: progress in exploring new environments for novel antibiotics. NPJ Antimicrob Resist. 2024, 2:8. 10.1038\/s44259-024-00025-8","journal-title":"NPJ Antimicrob Resist"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10094274","article-title":"Strategies to minimize antibiotic resistance","volume":"10","author":"Lee CR","year":"2013","unstructured":"Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013, 10:4274-305. 10.3390\/ijerph10094274","journal-title":"Int J Environ Res Public Health"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.7b03623","article-title":"Toward a comprehensive strategy to mitigate dissemination of environmental sources of antibiotic resistance","volume":"51","author":"Vikesland PJ","year":"2017","unstructured":"Vikesland PJ, Pruden A, Alvarez PJ, et al.. Toward a comprehensive strategy to mitigate dissemination of environmental sources of antibiotic resistance. Environ Sci Technol. 2017, 51:13061-9. 10.1021\/acs.est.7b03623","journal-title":"Environ Sci Technol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee A","year":"1994","unstructured":"Banerjee A, Dubnau E, Quemard A, et al.. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994, 263:227-30. 10.1126\/science.8284673","journal-title":"Science"},{"key":"ref85","unstructured":"World Health Organization Country Office for India and Department of Biotechnology, Government of India. Indian priority pathogen list. (2025). Accessed: October 27, 2025: https:\/\/dbtindia.gov.in\/sites\/default\/files\/IPPL_final.pdf."},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61265-2","article-title":"Continuing challenge of infectious diseases in India","volume":"377","author":"John TJ","year":"2011","unstructured":"John TJ, Dandona L, Sharma VP, Kakkar M. Continuing challenge of infectious diseases in India. Lancet. 2011, 377:252-269. 10.1016\/S0140-6736(10)61265-2","journal-title":"Lancet"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1186\/cc13948","article-title":"The future of antibiotics","volume":"18","author":"Spellberg B","year":"2014","unstructured":"Spellberg B. The future of antibiotics. Crit Care. 2014, 18:228. 10.1186\/cc13948","journal-title":"Crit Care"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_275_19","article-title":"India's National Action Plan for antimicrobial resistance - an overview of the context, status, and way ahead","volume":"8","author":"Ranjalkar J","year":"2019","unstructured":"Ranjalkar J, Chandy SJ. India's National Action Plan for antimicrobial resistance - an overview of the context, status, and way ahead. J Family Med Prim Care. 2019, 8:1828-34. 10.4103\/jfmpc.jfmpc_275_19","journal-title":"J Family Med Prim Care"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-024-01176-4","article-title":"One health initiative to mitigate the challenge of antimicrobial resistance in the perspectives of developing countries","volume":"48","author":"Tesema MY","year":"2024","unstructured":"Tesema MY, Birhanu AG. One health initiative to mitigate the challenge of antimicrobial resistance in the perspectives of developing countries. Bull Natl Res Cent. 2024, 48:Article number 19. 10.1186\/s42269-024-01176-4","journal-title":"Bull Natl Res Cent"},{"key":"ref90","unstructured":"Indian Council of Medical Research. Annual report January 2023 to December 2023. (2023). Accessed: October 27, 2025: https:\/\/www.icmr.gov.in\/icmrobject\/uploads\/Documents\/1725536060_annual_report_2023.pdf."},{"key":"ref91","unstructured":"World Health Organization. Global tuberculosis report 2024. (2025). Accessed: October 27, 2025: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100993","article-title":"Socioeconomic status and the risk for colonisation or infection with priority bacterial pathogens: a global evidence map","volume":"6","author":"Blackmon S","year":"2025","unstructured":"Blackmon S, Avendano EE, Nirmala N, et al.. Socioeconomic status and the risk for colonisation or infection with priority bacterial pathogens: a global evidence map. Lancet Microbe. 2025, 6:100993. 10.1016\/j.lanmic.2024.100993","journal-title":"Lancet Microbe"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1134\/S000368381902011X","article-title":"Antibiotic resistance: Modern approaches and ways to overcome it (review)","volume":"55","author":"Mikhaleva TV","year":"2019","unstructured":"Mikhaleva TV, Zakharova OI, Ilyasov PV. Antibiotic resistance: Modern approaches and ways to overcome it (review). Appl Biochem Microbiol. 2019, 55:99-106. 10.1134\/S000368381902011X","journal-title":"Appl Biochem Microbiol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1134\/S0026893324700511","article-title":"Antibiotic resistance: threats and search for solution","volume":"58","author":"Kochetkov SN","year":"2024","unstructured":"Kochetkov SN. Antibiotic resistance: threats and search for solution. Mol Biol. 2024, 58:971-979. 10.1134\/S0026893324700511","journal-title":"Mol Biol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305465120","article-title":"Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis","volume":"120","author":"Mehrotra T","year":"2023","unstructured":"Mehrotra T, Konar D, Pragasam AK, et al.. Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis. Proc Natl Acad Sci U S A. 2023, 120:e2305465120. 10.1073\/pnas.2305465120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial resistance in bacteria: Mechanisms, evolution, and persistence","volume":"88","author":"Christaki E","year":"2020","unstructured":"Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: Mechanisms, evolution, and persistence. J Mol Evol. 2020, 88:26-40. 10.1007\/s00239-019-09914-3","journal-title":"J Mol Evol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1951705","article-title":"Antimicrobial resistance in low- and middle-income countries: current status and future directions","volume":"20","author":"Sulis G","year":"2022","unstructured":"Sulis G, Sayood S, Gandra S. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther. 2022, 20:147-60. 10.1080\/14787210.2021.1951705","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-022-12175-8","article-title":"Antimicrobial resistance: new insights and therapeutic implications","volume":"106","author":"Sheikh BA","year":"2022","unstructured":"Sheikh BA, Bhat BA, Mir MA. Antimicrobial resistance: new insights and therapeutic implications. Appl Microbiol Biotechnol. 2022, 106:6427-40. 10.1007\/s00253-022-12175-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1434140","article-title":"Editorial: Reviews in antibiotic resistance and new antimicrobial drugs","volume":"14","author":"Kaushik S","year":"2024","unstructured":"Kaushik S. Editorial: Reviews in antibiotic resistance and new antimicrobial drugs. Front Cell Infect Microbiol. 2024, 14:1434140. 10.3389\/fcimb.2024.1434140","journal-title":"Front Cell Infect Microbiol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-03912-8","article-title":"The fight against antimicrobial resistance","volume":"624","author":"Nogrady B","year":"2023","unstructured":"Nogrady B. The fight against antimicrobial resistance. Nat. 2023, 624:30-32. 10.1038\/d41586-023-03912-8","journal-title":"Nat"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-021-00910-z","article-title":"Mechanism of drug resistance in bacteria: efflux pump modulation for designing of new antibiotic enhancers","volume":"66","author":"Mohanty H","year":"2021","unstructured":"Mohanty H, Pachpute S, Yadav RP. Mechanism of drug resistance in bacteria: efflux pump modulation for designing of new antibiotic enhancers. Folia Microbiol (Praha). 2021, 66:727-39. 10.1007\/s12223-021-00910-z","journal-title":"Folia Microbiol (Praha)"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita JM","year":"2016","unstructured":"Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.VMBF-0016-2015","journal-title":"Microbiol Spectr"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00820-y","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume":"21","author":"Darby EM","year":"2023","unstructured":"Darby EM, Trampari E, Siasat P, et al.. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023, 21:280-95. 10.1038\/s41579-022-00820-y","journal-title":"Nat Rev Microbiol"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00551","article-title":"A new strategy to fight antimicrobial resistance: the revival of old antibiotics","volume":"5","author":"Cassir N","year":"2014","unstructured":"Cassir N, Rolain JM, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 2014, 5:551. 10.3389\/fmicb.2014.00551","journal-title":"Front Microbiol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-018-0136-8","article-title":"Prevention strategies to combat antimicrobial resistance in children in resource-limited settings","volume":"5","author":"Diaz A","year":"2018","unstructured":"Diaz A, Antonara S, Barton T. Prevention strategies to combat antimicrobial resistance in children in resource-limited settings. Curr Trop Med Rep. 2018, 5:5-15. 10.1007\/s40475-018-0136-8","journal-title":"Curr Trop Med Rep"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-023-03699-2","article-title":"A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance","volume":"205","author":"Chen L","year":"2023","unstructured":"Chen L, Kumar S, Wu H. A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance. Arch Microbiol. 2023, 205:356. 10.1007\/s00203-023-03699-2","journal-title":"Arch Microbiol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8925.4529","article-title":"Strategies to combat antimicrobial resistance","volume":"8","author":"Uchil RR","year":"2014","unstructured":"Uchil RR, Kohli GS, Katekhaye VM, Swami OC. Strategies to combat antimicrobial resistance. J Clin Diagn Res. 2014, 8:ME01-4. 10.7860\/JCDR\/2014\/8925.4529","journal-title":"J Clin Diagn Res"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-024-04133-x","article-title":"Antimicrobial peptide-based strategies to overcome antimicrobial resistance","volume":"206","author":"Girdhar M","year":"2024","unstructured":"Girdhar M, Sen A, Nigam A, et al.. Antimicrobial peptide-based strategies to overcome antimicrobial resistance. Arch Microbiol. 2024, 206:411. 10.1007\/s00203-024-04133-x","journal-title":"Arch Microbiol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19542-2","article-title":"Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance","volume":"24","author":"Zay Ya K","year":"2024","unstructured":"Zay Ya K, Lambiris MJ, Levine GA, et al.. Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance. BMC Public Health. 2024, 24:2297. 10.1186\/s12889-024-19542-2","journal-title":"BMC Public Health"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-008-0073-0","article-title":"Emerging and re-emerging bacterial diseases in India","volume":"33","author":"Chugh TD","year":"2008","unstructured":"Chugh TD. Emerging and re-emerging bacterial diseases in India. J Biosci. 2008, 33:549-55. 10.1007\/s12038-008-0073-0","journal-title":"J Biosci"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103175","article-title":"Antimicrobial prescription patterns in tertiary care centres in India: a multicentric point prevalence survey","volume":"82","author":"Bhattacharjee S","year":"2025","unstructured":"Bhattacharjee S, Mothsara C, Shafiq N, et al.. Antimicrobial prescription patterns in tertiary care centres in India: a multicentric point prevalence survey. EClinicalMedicine. 2025, 82:103175. 10.1016\/j.eclinm.2025.103175","journal-title":"EClinicalMedicine"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6403250","article-title":"Knowledge and attitude toward antibiotic use and identification of financially feasible options to curb the spread of antibiotics in environment","volume":"2023","author":"Krishna M","year":"2023","unstructured":"Krishna M, Makwana N, Kakde GS, et al.. Knowledge and attitude toward antibiotic use and identification of financially feasible options to curb the spread of antibiotics in environment. Can J Infect Dis Med Microbiol. 2023, 2023:6403250. 10.1155\/2023\/6403250","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2021.100717","article-title":"Knowledge, attitude, and practices related to antibiotic use and resistance among the general public of coastal south Karnataka, India - A cross-sectional survey","volume":"11","author":"Bhardwaj K","year":"2021","unstructured":"Bhardwaj K, Shenoy MS, Baliga S, et al.. Knowledge, attitude, and practices related to antibiotic use and resistance among the general public of coastal south Karnataka, India - A cross-sectional survey. Clin Epidemiol Glob Health. 2021, 11:10.1016\/j.cegh.2021.100717","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.3233\/JRS-210020","article-title":"Antibiotic misuse and improper practices in India: Identifying the scope to improve through a narrative review","volume":"33","author":"Pereira B","year":"2022","unstructured":"Pereira B, Kulkarni S. Antibiotic misuse and improper practices in India: Identifying the scope to improve through a narrative review. Int J Risk Saf Med. 2022, 33:357-64. 10.3233\/JRS-210020","journal-title":"Int J Risk Saf Med"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-629","article-title":"Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India","volume":"10","author":"Sahoo KC","year":"2010","unstructured":"Sahoo KC, Tamhankar AJ, Johansson E, Lundborg CS. Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India. BMC Public Health. 2010, 10:629. 10.1186\/1471-2458-10-629","journal-title":"BMC Public Health"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2024.101771","article-title":"Determinants of antibiotic use\/misuse from patients' and health providers\u2019 perspective - A descriptive analysis from coastal Karnataka, India","volume":"29","author":"Jain S","year":"2024","unstructured":"Jain S, Rao CR, Goyal S. Determinants of antibiotic use\/misuse from patients' and health providers\u2019 perspective - A descriptive analysis from coastal Karnataka, India. Clin Epidemiol Glob Health. 2024, 29:Article number 101771. 10.1016\/j.cegh.2024.101771","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54250-2","article-title":"Determinants of private-sector antibiotic consumption in India: findings from a quasi-experimental fixed-effects regression analysis using cross-sectional time-series data, 2011-2019","volume":"14","author":"Koya SF","year":"2024","unstructured":"Koya SF, Ganesh S, Selvaraj S, et al.. Determinants of private-sector antibiotic consumption in India: findings from a quasi-experimental fixed-effects regression analysis using cross-sectional time-series data, 2011-2019. Sci Rep. 2024, 14:5052. 10.1038\/s41598-024-54250-2","journal-title":"Sci Rep"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258698","article-title":"Factors influencing inappropriate use of antibiotics: Findings from a nationwide survey of the general public in Malaysia","volume":"16","author":"Wong LP","year":"2021","unstructured":"Wong LP, Alias H, Husin SA, et al.. Factors influencing inappropriate use of antibiotics: Findings from a nationwide survey of the general public in Malaysia. PLoS One. 2021, 16:e0258698. 10.1371\/journal.pone.0258698","journal-title":"PLoS One"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmq059","article-title":"Factors influencing primary care physicians to prescribe antibiotics in Delhi India","volume":"27","author":"Kotwani A","year":"2010","unstructured":"Kotwani A, Wattal C, Katewa S, et al.. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010, 27:684-90. 10.1093\/fampra\/cmq059","journal-title":"Fam Pract"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdv072","article-title":"Medication misuse in India: a major public health issue in India","volume":"38","author":"Porter G","year":"2016","unstructured":"Porter G, Grills N. Medication misuse in India: a major public health issue in India. J Public Health (Oxf). 2016, 38:e150-7. 10.1093\/pubmed\/fdv072","journal-title":"J Public Health (Oxf)"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091123","article-title":"Over-the-counter sale of antibiotics in India: a qualitative study of providers\u2019 perspectives across two states","volume":"10","author":"Kotwani A","year":"2021","unstructured":"Kotwani A, Joshi J, Lamkang AS. Over-the-counter sale of antibiotics in India: a qualitative study of providers\u2019 perspectives across two states. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10091123","journal-title":"Antibiotics (Basel)"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1277628","article-title":"Social and cultural determinants of antibiotics prescriptions: analysis from a public community health centre in North India","volume":"15","author":"Mukherjee A","year":"2024","unstructured":"Mukherjee A, Surial R, Sahay S, et al.. Social and cultural determinants of antibiotics prescriptions: analysis from a public community health centre in North India. Front Pharmacol. 2024, 15:1277628. 10.3389\/fphar.2024.1277628","journal-title":"Front Pharmacol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4261-4","article-title":"Social determinants of antibiotic misuse: a qualitative study of community members in Haryana, India","volume":"17","author":"Barker AK","year":"2017","unstructured":"Barker AK, Brown K, Ahsan M, et al.. Social determinants of antibiotic misuse: a qualitative study of community members in Haryana, India. BMC Public Health. 2017, 17:333. 10.1186\/s12889-017-4261-4","journal-title":"BMC Public Health"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00380-9","article-title":"Social factors influencing the acquisition of antibiotics without prescription in Kerala State, south India","volume":"50","author":"Saradamma RD","year":"2000","unstructured":"Saradamma RD, Higginbotham N, Nichter M. Social factors influencing the acquisition of antibiotics without prescription in Kerala State, south India. Soc Sci Med. 2000, 50:891-903. 10.1016\/S0277-9536(99)00380-9","journal-title":"Soc Sci Med"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01694-5","article-title":"Demanding attention to self-medication with antibiotics","volume":"404","author":"Subramanian U","year":"2024","unstructured":"Subramanian U, Venkidasamy B. Demanding attention to self-medication with antibiotics. Lancet. 2024, 404:1016-1017. 10.1016\/S0140-6736(24)01694-5","journal-title":"Lancet"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2024.11.008","article-title":"Prevalence and patterns of self-medication practices in India: A systematic review and meta-analysis","volume":"81","author":"Chaudhary V","year":"2025","unstructured":"Chaudhary V, Kumari S, Sharma B, et al.. Prevalence and patterns of self-medication practices in India: A systematic review and meta-analysis. Med J Armed Forces India. 2025, 81:377-85. 10.1016\/j.mjafi.2024.11.008","journal-title":"Med J Armed Forces India"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33917","article-title":"Prevalence, pattern, and reasons for self-medication: A community-based cross-sectional study from central India","volume":"15","author":"Rathod P","year":"2023","unstructured":"Rathod P, Sharma S, Ukey U, et al.. Prevalence, pattern, and reasons for self-medication: A community-based cross-sectional study from central India. Cureus. 2023, 15:e33917. 10.7759\/cureus.33917","journal-title":"Cureus"},{"key":"ref128","article-title":"Self medication: A potentially avoidable cause of antibiotic misuse and resistance","volume":"2","author":"Patil AD","year":"2017","unstructured":"Patil AD. Self medication: A potentially avoidable cause of antibiotic misuse and resistance. Int J Basic Clin Pharmacol. 2017, 2:498-499.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010078","article-title":"Knowledge, attitudes, motivations, expectations, and systemic factors regarding antimicrobial use amongst community members seeking care at the primary healthcare level: a scoping review","volume":"14","author":"Ramdas N","year":"2025","unstructured":"Ramdas N, Meyer JC, Schellack N, et al.. Knowledge, attitudes, motivations, expectations, and systemic factors regarding antimicrobial use amongst community members seeking care at the primary healthcare level: a scoping review. Antibiotics (Basel). 2025, 14:10.3390\/antibiotics14010078","journal-title":"Antibiotics (Basel)"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.10.007","article-title":"India's National Action Plan on Antimicrobial Resistance: a critical perspective","volume":"27","author":"Nair M","year":"2021","unstructured":"Nair M, Zeegers MP, Varghese GM, Burza S. India's National Action Plan on Antimicrobial Resistance: a critical perspective. J Glob Antimicrob Resist. 2021, 27:236-8. 10.1016\/j.jgar.2021.10.007","journal-title":"J Glob Antimicrob Resist"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2025.106534","article-title":"Formulating antibiotic policy: analysis of India's ban on colistin use in food producing animals","volume":"240","author":"Hennessey M","year":"2025","unstructured":"Hennessey M, Alarcon P, Samanta I, et al.. Formulating antibiotic policy: analysis of India's ban on colistin use in food producing animals. Prev Vet Med. 2025, 240:106534. 10.1016\/j.prevetmed.2025.106534","journal-title":"Prev Vet Med"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.4103\/jcrsm.jcrsm_14_24","article-title":"Community awareness, perceptions, and behavior regarding antibiotic consumption in an urban area of Pondicherry","volume":"10","author":"Niranjhanadevi C","year":"2024","unstructured":"Niranjhanadevi C, Stalin P. Community awareness, perceptions, and behavior regarding antibiotic consumption in an urban area of Pondicherry. J Current Res Sci Med. 2024, 10:25-30. 10.4103\/jcrsm.jcrsm_14_24","journal-title":"J Current Res Sci Med"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac112","article-title":"Antibiotic consumption in India: geographical variations and temporal changes between 2011 and 2019","volume":"4","author":"Fazaludeen Koya S","year":"2022","unstructured":"Fazaludeen Koya S, Ganesh S, Selvaraj S, et al.. Antibiotic consumption in India: geographical variations and temporal changes between 2011 and 2019. JAC Antimicrob Resist. 2022, 4:dlac112. 10.1093\/jacamr\/dlac112","journal-title":"JAC Antimicrob Resist"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00993-0","article-title":"Alternative therapeutic strategies to treat antibiotic-resistant pathogens","volume":"22","author":"MacNair CR","year":"2024","unstructured":"MacNair CR, Rutherford ST, Tan MW. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat Rev Microbiol. 2024, 22:262-75. 10.1038\/s41579-023-00993-0","journal-title":"Nat Rev Microbiol"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.3390\/life13051073","article-title":"Modern trends in natural antibiotic discovery","volume":"13","author":"Baranova AA","year":"2023","unstructured":"Baranova AA, Alferova VA, Korshun VA, Tyurin AP. Modern trends in natural antibiotic discovery. Life (Basel). 2023, 13:10.3390\/life13051073","journal-title":"Life (Basel)"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.122586","article-title":"Antibiotic resistance in wastewater: Indian scenario","volume":"337","author":"Kapley A","year":"2023","unstructured":"Kapley A, Sheeraz MS, Kukade S, et al.. Antibiotic resistance in wastewater: Indian scenario. Environ Pollut. 2023, 337:122586. 10.1016\/j.envpol.2023.122586","journal-title":"Environ Pollut"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan R","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, et al.. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013, 13:1057-1098. 10.1016\/s1473-3099(13)70318-9","journal-title":"Lancet Infect Dis"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw1944","article-title":"Global trends in antimicrobial resistance in animals in low- and middle-income countries","volume":"365","author":"Van Boeckel TP","year":"2019","unstructured":"Van Boeckel TP, Pires J, Silvester R, et al.. Global trends in antimicrobial resistance in animals in low- and middle-income countries. Science. 2019, 365:10.1126\/science.aaw1944","journal-title":"Science"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.717809","article-title":"A review on occurrence and spread of antibiotic resistance in wastewaters and in wastewater treatment plants: mechanisms and perspectives","volume":"12","author":"Uluseker C","year":"2021","unstructured":"Uluseker C, Kaster KM, Thorsen K, et al.. A review on occurrence and spread of antibiotic resistance in wastewaters and in wastewater treatment plants: mechanisms and perspectives. Front Microbiol. 2021, 12:717809. 10.3389\/fmicb.2021.717809","journal-title":"Front Microbiol"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1007\/s11270-023-06479-2","article-title":"High antibiotic resistance in indian sewage shows distinct trends and might be disjoint from in-situ antibiotic levels","volume":"234","author":"Singh KS","year":"2023","unstructured":"Singh KS, Keer A, Zed A, et al.. High antibiotic resistance in indian sewage shows distinct trends and might be disjoint from in-situ antibiotic levels. Water Air Soil Pollut. 2023, 234:467. 10.1007\/s11270-023-06479-2","journal-title":"Water Air Soil Pollut"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0710-x","article-title":"Sewage effluent from an Indian hospital harbors novel carbapenemases and integron-borne antibiotic resistance genes","volume":"7","author":"Marathe NP","year":"2019","unstructured":"Marathe NP, Berglund F, Razavi M, et al.. Sewage effluent from an Indian hospital harbors novel carbapenemases and integron-borne antibiotic resistance genes. Microbiome. 2019, 7:97. 10.1186\/s40168-019-0710-x","journal-title":"Microbiome"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00137-4","article-title":"Evaluating the relationship between community water and sanitation access and the global burden of antibiotic resistance: an ecological study","volume":"4","author":"Fuhrmeister ER","year":"2023","unstructured":"Fuhrmeister ER, Harvey AP, Nadimpalli ML, et al.. Evaluating the relationship between community water and sanitation access and the global burden of antibiotic resistance: an ecological study. Lancet Microbe. 2023, 4:e591-600. 10.1016\/S2666-5247(23)00137-4","journal-title":"Lancet Microbe"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1007\/698_2020_608","article-title":"Antibiotic resistance and sanitation in India: Current situation and future perspectives","author":"Sasikaladevi R","unstructured":"Sasikaladevi R, Kiruthika Eswari V, Nambi IM. Antibiotic resistance and sanitation in India: Current situation and future perspectives. Antibiotic Resistance in the Environment: A Worldwide Overview. Manaia CM, Donner E, Vaz-Moreira I, Hong P (ed): Springer International Publishing, 217-244. 10.1007\/698_2020_608"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-0691.2004.1004.x","article-title":"The need for new antibiotics","volume":"10 Suppl 4","author":"Livermore DM","year":"2004","unstructured":"Livermore DM. The need for new antibiotics. Clin Microbiol Infect. 2004, 10 Suppl 4:1-9. 10.1111\/j.1465-0691.2004.1004.x","journal-title":"Clin Microbiol Infect"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-021-0649-z","article-title":"Rediscovery of antimicrobial peptides as therapeutic agents","volume":"59","author":"Ryu M","year":"2021","unstructured":"Ryu M, Park J, Yeom JH, et al.. Rediscovery of antimicrobial peptides as therapeutic agents. J Microbiol. 2021, 59:113-23. 10.1007\/s12275-021-0649-z","journal-title":"J Microbiol"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke M","year":"2021","unstructured":"Miethke M, Pieroni M, Weber T, et al.. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem. 2021, 5:726-49. 10.1038\/s41570-021-00313-1","journal-title":"Nat Rev Chem"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings MI","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019, 51:72-80. 10.1016\/j.mib.2019.10.008","journal-title":"Curr Opin Microbiol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1021\/id500052s","article-title":"Solving the antibiotic crisis","volume":"1","author":"Wright GD","year":"2015","unstructured":"Wright GD. Solving the antibiotic crisis. ACS Infect Dis. 2015, 1:80-4. 10.1021\/id500052s","journal-title":"ACS Infect Dis"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2009.0439","article-title":"Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals","volume":"29","author":"Kesselheim AS","year":"2010","unstructured":"Kesselheim AS, Outterson K. Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals. Health Aff (Millwood). 2010, 29:1689-96. 10.1377\/hlthaff.2009.0439","journal-title":"Health Aff (Millwood)"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1057\/s41599-024-03452-0","article-title":"Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem","volume":"11","author":"Wells N","year":"2024","unstructured":"Wells N, Nguyen V-K, Harbarth S. Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem. Humanit Soc Sci Commun. 2024, 11:Article number 941. 10.1057\/s41599-024-03452-0","journal-title":"Humanit Soc Sci Commun"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2014.898717","article-title":"New business models for antibiotic innovation","volume":"119","author":"So AD","year":"2014","unstructured":"So AD, Shah TA. New business models for antibiotic innovation. Ups J Med Sci. 2014, 119:176-80. 10.3109\/03009734.2014.898717","journal-title":"Ups J Med Sci"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.3390\/biology12010101","article-title":"Landscape of push funding in antibiotic research: Current status and way forward","volume":"12","author":"Wasan H","year":"2023","unstructured":"Wasan H, Singh D, Reeta KH, Gupta YK. Landscape of push funding in antibiotic research: Current status and way forward. Biology (Basel). 2023, 12:10.3390\/biology12010101","journal-title":"Biology (Basel)"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-022-00466-4","article-title":"Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008-2018","volume":"15","author":"Selvaraj S","year":"2022","unstructured":"Selvaraj S, Farooqui HH, Mehta A, Mathur MR. Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008-2018. J Pharm Policy Pract. 2022, 15:68. 10.1186\/s40545-022-00466-4","journal-title":"J Pharm Policy Pract"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1177\/09685332211020786","article-title":"Over-the-counter sales of antibiotics for human use in India: The challenges and opportunities for regulation","volume":"21","author":"Porter G","year":"2021","unstructured":"Porter G, Kotwani A, Bhullar L, Joshi J. Over-the-counter sales of antibiotics for human use in India: The challenges and opportunities for regulation. Med Law Int. 2021, 21:147-173. 10.1177\/09685332211020786","journal-title":"Med Law Int"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70189-4","article-title":"Antimicrobial resistance in developing countries. Part I: Recent trends and current status","volume":"5","author":"Okeke IN","year":"2005","unstructured":"Okeke IN, Laxminarayan R, Bhutta ZA, et al.. Antimicrobial resistance in developing countries. Part I: Recent trends and current status. Lancet Infect Dis. 2005, 5:481-493. 10.1016\/S1473-3099(05)70189-4","journal-title":"Lancet Infect Dis"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2024.07.006","article-title":"Antimicrobial resistance: current challenges and future directions","volume":"81","author":"Puri B","year":"2025","unstructured":"Puri B, Vaishya R, Vaish A. Antimicrobial resistance: current challenges and future directions. Med J Armed Forces India. 2025, 81:247-58. 10.1016\/j.mjafi.2024.07.006","journal-title":"Med J Armed Forces India"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks355","article-title":"Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India","volume":"68","author":"Chandy SJ","year":"2013","unstructured":"Chandy SJ, Thomas K, Mathai E, et al.. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother. 2013, 68:229-36. 10.1093\/jac\/dks355","journal-title":"J Antimicrob Chemother"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_537_21","article-title":"Adopting an intersectoral One Health approach in India: Time for One Health committees","volume":"153","author":"Dasgupta R","year":"2021","unstructured":"Dasgupta R, Tomley F, Alders R, et al.. Adopting an intersectoral One Health approach in India: Time for One Health committees. Indian J Med Res. 2021, 153:281-6. 10.4103\/ijmr.IJMR_537_21","journal-title":"Indian J Med Res"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26664","article-title":"Implementation of antimicrobial stewardship in the healthcare setting","volume":"14","author":"Bankar NJ","year":"2022","unstructured":"Bankar NJ, Ugemuge S, Ambad RS, et al.. Implementation of antimicrobial stewardship in the healthcare setting. Cureus. 2022, 14:e26664. 10.7759\/cureus.26664","journal-title":"Cureus"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxaf012","article-title":"Sustainable solutions to the continuous threat of antimicrobial resistance","volume":"3","author":"Spellberg B","year":"2025","unstructured":"Spellberg B, Gilbert DN, Baym M, et al.. Sustainable solutions to the continuous threat of antimicrobial resistance. Health Aff Sch. 2025, 3:qxaf012. 10.1093\/haschl\/qxaf012","journal-title":"Health Aff Sch"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: A worldwide challenge","volume":"387","author":"Laxminarayan R","year":"2016","unstructured":"Laxminarayan R, Matsoso P, Pant S, et al.. Access to effective antimicrobials: A worldwide challenge. Lancet. 2016, 387:168-175. 10.1016\/s0140-6736(15)00474-2","journal-title":"Lancet"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1007\/s10989-023-10561-y","article-title":"Antibiotic-peptide conjugation against multi-drug resistant pathogens: A comprehensive review for therapeutics and drug delivery strategies","volume":"29","author":"Kalimuthu K","year":"2023","unstructured":"Kalimuthu K, Srinivasan NR, Govindarajan G. Antibiotic-peptide conjugation against multi-drug resistant pathogens: A comprehensive review for therapeutics and drug delivery strategies. Int J Pept Res Ther. 2023, 29:91. 10.1007\/s10989-023-10561-y","journal-title":"Int J Pept Res Ther"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06873-0","article-title":"A novel antibiotic class targeting the lipopolysaccharide transporter","volume":"625","author":"Zampaloni C","year":"2024","unstructured":"Zampaloni C, Mattei P, Bleicher K, et al.. A novel antibiotic class targeting the lipopolysaccharide transporter. Nature. 2024, 625:566-71. 10.1038\/s41586-023-06873-0","journal-title":"Nature"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1007\/s10989-024-10623-9","article-title":"Antimicrobial peptides: potential alternative to antibiotics and overcoming limitations for future therapeutic applications","volume":"30","author":"Somase V","year":"2024","unstructured":"Somase V, Desai SA, Patel VP, et al.. Antimicrobial peptides: potential alternative to antibiotics and overcoming limitations for future therapeutic applications. Int J Pept Res Ther. 2024, 30:Article number 45. 10.1007\/s10989-024-10623-9","journal-title":"Int J Pept Res Ther"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100968","article-title":"Tackling antimicrobial resistance: recognising the proposed five blind spots can accelerate progress","volume":"6","author":"Pai M","year":"2025","unstructured":"Pai M, Gandra S, Thapa P, Carmona S. Tackling antimicrobial resistance: recognising the proposed five blind spots can accelerate progress. Lancet Microbe. 2025, 6:100968. 10.1016\/j.lanmic.2024.100968","journal-title":"Lancet Microbe"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2025.116949","article-title":"Understanding antimicrobial resistance (AMR) mechanisms and advancements in AMR diagnostics","volume":"113","author":"Sinha S","year":"2025","unstructured":"Sinha S, Upadhyay LS. Understanding antimicrobial resistance (AMR) mechanisms and advancements in AMR diagnostics. Diagn Microbiol Infect Dis. 2025, 113:116949. 10.1016\/j.diagmicrobio.2025.116949","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13203246","article-title":"Current and future technologies for the detection of antibiotic-resistant bacteria","volume":"13","author":"Yamin D","year":"2023","unstructured":"Yamin D, Uskokovi\u0107 V, Wakil AM, et al.. Current and future technologies for the detection of antibiotic-resistant bacteria. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13203246","journal-title":"Diagnostics (Basel)"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2020.100015","article-title":"Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic","volume":"1","author":"Konwar AN","year":"2020","unstructured":"Konwar AN, Borse V. Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic. Sens Int. 2020, 1:100015. 10.1016\/j.sintl.2020.100015","journal-title":"Sens Int"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c03856","article-title":"Point-of-care for evaluating antimicrobial resistance through the adoption of functional materials","volume":"94","author":"Singh S","year":"2022","unstructured":"Singh S, Numan A, Cinti S. Point-of-care for evaluating antimicrobial resistance through the adoption of functional materials. Anal Chem. 2022, 94:26-40. 10.1021\/acs.analchem.1c03856","journal-title":"Anal Chem"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015493","article-title":"The combination of antibiotic and non-antibiotic compounds improves antibiotic efficacy against multidrug-resistant bacteria","volume":"24","author":"Xiao G","year":"2023","unstructured":"Xiao G, Li J, Sun Z. The combination of antibiotic and non-antibiotic compounds improves antibiotic efficacy against multidrug-resistant bacteria. Int J Mol Sci. 2023, 24:10.3390\/ijms242015493","journal-title":"Int J Mol Sci"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.04.003","article-title":"The future of antibiotics: Emerging technologies and stewardship","volume":"24","author":"Fortman JL","year":"2016","unstructured":"Fortman JL, Mukhopadhyay A. The future of antibiotics: Emerging technologies and stewardship. Trends Microbiol. 2016, 24:515-7. 10.1016\/j.tim.2016.04.003","journal-title":"Trends Microbiol"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-016-0181-2","article-title":"Integrating one health in national health policies of developing countries: India's lost opportunities","volume":"5","author":"Chatterjee P","year":"2016","unstructured":"Chatterjee P, Kakkar M, Chaturvedi S. Integrating one health in national health policies of developing countries: India's lost opportunities. Infect Dis Poverty. 2016, 5:87. 10.1186\/s40249-016-0181-2","journal-title":"Infect Dis Poverty"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006961","article-title":"Shortage of essential antimicrobials: a major challenge to global health security","volume":"6","author":"Shafiq N","year":"2021","unstructured":"Shafiq N, Pandey AK, Malhotra S, et al.. Shortage of essential antimicrobials: a major challenge to global health security. BMJ Glob Health. 2021, 6:10.1136\/bmjgh-2021-006961","journal-title":"BMJ Glob Health"},{"key":"ref174","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. (2025). Accessed: October 27, 2025: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/1a487887-e162-46a0-8aef-802907c66070\/content."},{"key":"ref175","unstructured":"Ministry of Health & Family Welfare, Government of India. National action plan on antimicrobial resistance (NAP-AMR) 2017-2021. (2025). Accessed: October 27, 2025: https:\/\/ncdc.mohfw.gov.in\/wp-content\/uploads\/2024\/03\/File645.pdf."},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa076","article-title":"The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008-18","volume":"2","author":"Farooqui HH","year":"2020","unstructured":"Farooqui HH, Selvaraj S, Mehta A, Mathur MR. The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008-18. JAC Antimicrob Resist. 2020, 2:dlaa076. 10.1093\/jacamr\/dlaa076","journal-title":"JAC Antimicrob Resist"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1811_21","article-title":"The role of schedule H1 and red line campaign in improving antibiotic use in India","volume":"11","author":"Mathew P","year":"2022","unstructured":"Mathew P, Thomas SA, Chandy SJ. The role of schedule H1 and red line campaign in improving antibiotic use in India. J Family Med Prim Care. 2022, 11:2656-61. 10.4103\/jfmpc.jfmpc_1811_21","journal-title":"J Family Med Prim Care"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2687","article-title":"Antibiotic resistance and its containment in India","volume":"358","author":"Kakkar M","year":"2017","unstructured":"Kakkar M, Walia K, Vong S, et al.. Antibiotic resistance and its containment in India. BMJ. 2017, 358:j2687. 10.1136\/bmj.j2687","journal-title":"BMJ"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1191036","article-title":"Leveraging collaborative research networks against antimicrobial resistance in Asia","volume":"11","author":"He S","year":"2023","unstructured":"He S, Shrestha P, Henry AD, Legido-Quigley H. Leveraging collaborative research networks against antimicrobial resistance in Asia. Front Public Health. 2023, 11:1191036. 10.3389\/fpubh.2023.1191036","journal-title":"Front Public Health"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68932","article-title":"Multidisciplinary collaboration in combatting antimicrobial resistance: Insights and outcomes from the national alliance of medical professionals on antimicrobial resistance (NAMP-AMR) initiative","volume":"16","author":"Karthikeyan V","year":"2024","unstructured":"Karthikeyan V, Saini N, Nadarajan R, et al.. Multidisciplinary collaboration in combatting antimicrobial resistance: Insights and outcomes from the national alliance of medical professionals on antimicrobial resistance (NAMP-AMR) initiative. Cureus. 2024, 16:e68932. 10.7759\/cureus.68932","journal-title":"Cureus"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.4103\/jimph.Jimph_31_24","article-title":"Combating antimicrobial resistance in India: Challenges, progress, and the path forward with a one health approach","volume":"3","author":"Chauhan A","year":"2024","unstructured":"Chauhan A, Chauhan S. Combating antimicrobial resistance in India: Challenges, progress, and the path forward with a one health approach. Integr Med Public Health. 2024, 3:122-124. 10.4103\/jimph.Jimph_31_24","journal-title":"Integr Med Public Health"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78111-0","article-title":"Antimicrobial stewardship implementation in primary and secondary tier hospitals in India: interim findings from a need assessment study using mixed method design","volume":"14","author":"Debnath F","year":"2024","unstructured":"Debnath F, De RG, Chakraborty D, et al.. Antimicrobial stewardship implementation in primary and secondary tier hospitals in India: interim findings from a need assessment study using mixed method design. Sci Rep. 2024, 14:28068. 10.1038\/s41598-024-78111-0","journal-title":"Sci Rep"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2022.12.011","article-title":"Strengthening antimicrobial stewardship activities in secondary and primary public healthcare facilities in India: Insights from a qualitative study with stakeholders","volume":"41","author":"Kotwani A","year":"2023","unstructured":"Kotwani A, Gandra S. Strengthening antimicrobial stewardship activities in secondary and primary public healthcare facilities in India: Insights from a qualitative study with stakeholders. Indian J Med Microbiol. 2023, 41:59-63. 10.1016\/j.ijmmb.2022.12.011","journal-title":"Indian J Med Microbiol"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy290","article-title":"Implementation and impact of an antimicrobial stewardship program at a tertiary care center in south India","volume":"6","author":"Singh S","year":"2019","unstructured":"Singh S, Menon VP, Mohamed ZU, et al.. Implementation and impact of an antimicrobial stewardship program at a tertiary care center in south India. Open Forum Infect Dis. 2019, 6:ofy290. 10.1093\/ofid\/ofy290","journal-title":"Open Forum Infect Dis"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2022.02.003","article-title":"Impact of an antimicrobial stewardship intervention on usage of antibiotics in coronavirus disease-2019 at a tertiary care teaching hospital in India","volume":"3","author":"Borde K","year":"2022","unstructured":"Borde K, Medisetty MK, Muppala BS, et al..  Impact of an antimicrobial stewardship intervention on usage of antibiotics in coronavirus disease-2019 at a tertiary care teaching hospital in India. IJID Reg. 2022, 3:15-20. 10.1016\/j.ijregi.2022.02.003","journal-title":"IJID Reg"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20222756","article-title":"Antimicrobial stewardship program activities in India: An appraisal","volume":"11","author":"Chauhan J","year":"2022","unstructured":"Chauhan J, Chakraverty R, Pathan S. Antimicrobial stewardship program activities in India: An appraisal. Int J Basic Clin Pharmacol. 2022, 11:676-679. 10.18203\/2319-2003.ijbcp20222756","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam TF","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al.. Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016, 62:e51-77. 10.1093\/cid\/ciw118","journal-title":"Clin Infect Dis"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_951_17","article-title":"Antibiotic stewardship initiative in a Medicine unit of a tertiary care teaching hospital in India: a pilot study","volume":"150","author":"Swamy A","year":"2019","unstructured":"Swamy A, Sood R, Kapil A, et al.. Antibiotic stewardship initiative in a Medicine unit of a tertiary care teaching hospital in India: a pilot study. Indian J Med Res. 2019, 150:175-85. 10.4103\/ijmr.IJMR_951_17","journal-title":"Indian J Med Res"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.09.005","article-title":"The implementation and outcome of a 2-year prospective audit and feedback based antimicrobial stewardship program at a private tertiary care hospital","volume":"39","author":"Thakkar P","year":"2021","unstructured":"Thakkar P, Singhal T, Shah S, et al.. The implementation and outcome of a 2-year prospective audit and feedback based antimicrobial stewardship program at a private tertiary care hospital. Indian J Med Microbiol. 2021, 39:425-8. 10.1016\/j.ijmmb.2021.09.005","journal-title":"Indian J Med Microbiol"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_147_18","article-title":"Policy document on antimicrobial stewardship practices in India","volume":"149","author":"Walia K","year":"2019","unstructured":"Walia K, Ohri VC, Madhumathi J, Ramasubramanian V. Policy document on antimicrobial stewardship practices in India. Indian J Med Res. 2019, 149:180-4. 10.4103\/ijmr.IJMR_147_18","journal-title":"Indian J Med Res"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00873-9","article-title":"A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India","volume":"10","author":"Singh S","year":"2021","unstructured":"Singh S, Charani E, Devi S, et al.. A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India. Antimicrob Resist Infect Control. 2021, 10:32. 10.1186\/s13756-020-00873-9","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad124","article-title":"Addressing antimicrobial resistance through community engagement: a framework for developing contextually relevant and impactful behaviour change interventions","volume":"5","author":"Mitchell J","year":"2023","unstructured":"Mitchell J, Hawkings H, Latham S, et al.. Addressing antimicrobial resistance through community engagement: a framework for developing contextually relevant and impactful behaviour change interventions. JAC Antimicrob Resist. 2023, 5:dlad124. 10.1093\/jacamr\/dlad124","journal-title":"JAC Antimicrob Resist"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac112","article-title":"The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews","volume":"77","author":"Van Dort BA","year":"2022","unstructured":"Van Dort BA, Penm J, Ritchie A, Baysari MT. The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews. J Antimicrob Chemother. 2022, 77:1828-37. 10.1093\/jac\/dkac112","journal-title":"J Antimicrob Chemother"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(24)00198-5","article-title":"Using digital health technologies to optimise antimicrobial use globally","volume":"6","author":"Rawson TM","year":"2024","unstructured":"Rawson TM, Zhu N, Galiwango R, et al.. Using digital health technologies to optimise antimicrobial use globally. Lancet Digit Health. 2024, 6:914-925. 10.1016\/S2589-7500(24)00198-5","journal-title":"Lancet Digit Health"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2023.101183","article-title":"The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost","volume":"37","author":"Trotter NE","year":"2023","unstructured":"Trotter NE, Slight SP, Karimi R, et al.. The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost. Inform Med Unlocked. 2023, 37:Article number 101183. 10.1016\/j.imu.2023.101183","journal-title":"Inform Med Unlocked"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.3389\/frabi.2023.1214826","article-title":"Digital monitoring for data-driven antimicrobial stewardship: a process perspective from resource-constrained contexts in India","volume":"2","author":"Thakral Y","year":"2023","unstructured":"Thakral Y. Digital monitoring for data-driven antimicrobial stewardship: a process perspective from resource-constrained contexts in India. Front Antibiot. 2023, 2:1214826. 10.3389\/frabi.2023.1214826","journal-title":"Front Antibiot"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-021-00278-1","article-title":"Electronic health records and antimicrobial stewardship research: a narrative review","author":"Rezel-Potts E","year":"2022","unstructured":"Rezel-Potts E, Gulliford M. Electronic health records and antimicrobial stewardship research: a narrative review. Curr Epidemiol Rep. 2022, 1-10. 10.1007\/s40471-021-00278-1","journal-title":"Curr Epidemiol Rep"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30453-9","article-title":"Electronic health record data for antimicrobial prescribing","volume":"21","author":"Haeusler GM","year":"2021","unstructured":"Haeusler GM, Thursky KA. Electronic health record data for antimicrobial prescribing. Lancet Infect Dis. 2021, 21:155-157. 10.1016\/S1473-3099(20)30453-9","journal-title":"Lancet Infect Dis"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-024-02707-9","article-title":"A complex ePrescribing antimicrobial stewardship-based (ePAMS+) intervention for hospitals: mixed-methods feasibility trial results","volume":"24","author":"Weir CJ","year":"2024","unstructured":"Weir CJ, Hinder S, Adamestam I, et al.. A complex ePrescribing antimicrobial stewardship-based (ePAMS+) intervention for hospitals: mixed-methods feasibility trial results. BMC Med Inform Decis Mak. 2024, 24:301. 10.1186\/s12911-024-02707-9","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac598","article-title":"Antimicrobial prescribing in the telehealth setting: Framework for stewardship during a period of rapid acceleration within primary care","volume":"75","author":"Sine K","year":"2022","unstructured":"Sine K, Appaneal H, Dosa D, LaPlante KL. Antimicrobial prescribing in the telehealth setting: Framework for stewardship during a period of rapid acceleration within primary care. Clin Infect Dis. 2022, 75:2260-5. 10.1093\/cid\/ciac598","journal-title":"Clin Infect Dis"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-021-00256-7","article-title":"The emerging role of telehealth in antimicrobial stewardship: A systematic review and perspective","volume":"13","author":"Pierce J","year":"2021","unstructured":"Pierce J, Stevens MP. The emerging role of telehealth in antimicrobial stewardship: A systematic review and perspective. Curr Treat Options Infect Dis. 2021, 13:175-91. 10.1007\/s40506-021-00256-7","journal-title":"Curr Treat Options Infect Dis"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2023.100383","article-title":"Impact of improving infection control and antibiotic stewardship practices on nosocomial infections and antimicrobial resistance in an oncology centre from India","volume":"45","author":"Bansal N","year":"2023","unstructured":"Bansal N, Goyal P, Basu D, et al.. Impact of improving infection control and antibiotic stewardship practices on nosocomial infections and antimicrobial resistance in an oncology centre from India. Indian J Med Microbiol. 2023, 45:100383. 10.1016\/j.ijmmb.2023.100383","journal-title":"Indian J Med Microbiol"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3768","article-title":"Strengthening infection prevention and control and systematic surveillance of healthcare associated infections in India","volume":"358","author":"Swaminathan S","year":"2017","unstructured":"Swaminathan S, Prasad J, Dhariwal AC, et al.. Strengthening infection prevention and control and systematic surveillance of healthcare associated infections in India. BMJ. 2017, 358:j3768. 10.1136\/bmj.j3768","journal-title":"BMJ"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0189-9","article-title":"Barriers and facilitators to infection control at a hospital in northern India: a qualitative study","volume":"6","author":"Barker AK","year":"2017","unstructured":"Barker AK, Brown K, Siraj D, et al.. Barriers and facilitators to infection control at a hospital in northern India: a qualitative study. Antimicrob Resist Infect Control. 2017, 6:35. 10.1186\/s13756-017-0189-9","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.151702","article-title":"Delineating the impact of COVID-19 on antimicrobial resistance: an Indian perspective","volume":"818","author":"Seethalakshmi PS","year":"2022","unstructured":"Seethalakshmi PS, Charity OJ, Giakoumis T, et al.. Delineating the impact of COVID-19 on antimicrobial resistance: an Indian perspective. Sci Total Environ. 2022, 818:151702. 10.1016\/j.scitotenv.2021.151702","journal-title":"Sci Total Environ"},{"key":"ref206","doi-asserted-by":"publisher","DOI":"10.4103\/JIMPH.JIMPH_16_23","article-title":"COVID-19 pandemic, medications, and antimicrobial resistance in India: a cascade of events","volume":"2","author":"Sharma A","year":"2023","unstructured":"Sharma A, Inder D, Agarwal A, Garg D. COVID-19 pandemic, medications, and antimicrobial resistance in India: a cascade of events. JIMPH. 2023, 2:39-44. 10.4103\/JIMPH.JIMPH_16_23","journal-title":"JIMPH"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00173-7","article-title":"Rising antimicrobial resistance: an evolving epidemic in a pandemic","volume":"2","author":"Manesh A","year":"2021","unstructured":"Manesh A, Varghese GM. Rising antimicrobial resistance: an evolving epidemic in a pandemic. Lancet Microbe. 2021, 2:e419-20. 10.1016\/S2666-5247(21)00173-7","journal-title":"Lancet Microbe"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405726-strategies-and-recent-advances-in-tackling-antibacterial-resistance-in-india-a-comprehensive-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:44:13Z","timestamp":1761680653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405726-strategies-and-recent-advances-in-tackling-antibacterial-resistance-in-india-a-comprehensive-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":207,"URL":"https:\/\/doi.org\/10.7759\/cureus.95613","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}